Allstate stock reaches all-time high at $213.18 USD

Allstate Corp (NYSE:ALL)’s stock has reached an all-time high, hitting $213.18 USD, marking a significant milestone for the $55.8 billion insurance giant. According to InvestingPro data, the company trades at an attractive P/E ratio of 9.7x and boasts a "GREAT" overall financial health score. This achievement comes amid a robust year for the company, with its stock price experiencing an impressive 18.9% increase over the past 12 months. The surge reflects strong investor confidence and favorable market conditions, positioning Allstate as a standout performer in the financial sector. The company has maintained dividend payments for 33 consecutive years, with a current yield of 1.9%. As the company continues to capitalize on its strategic initiatives, stakeholders are closely monitoring its trajectory for further growth and stability. InvestingPro analysis suggests the stock may still be undervalued, with 12 analysts recently revising their earnings estimates upward.

In other recent news, Allstate reported a strong second quarter for 2025, with earnings per share (EPS) reaching $5.94, significantly beating the forecast of $3.32. Revenue also exceeded expectations, coming in at $16.6 billion compared to the projected $15.22 billion. This impressive performance led to a positive response from analysts and revisions in stock price targets. Keefe, Bruyette & Woods (KBW) raised their price target for Allstate to $246 from $237, citing the company’s quarterly outperformance and upward adjustments in earnings per share forecasts for the coming years. BMO Capital also increased its price target to $235 from $230, reflecting Allstate’s earnings beat and lower expense ratio, despite some challenges like weaker near-term buybacks. Wells Fargo (NYSE:WFC) adjusted its price target to $202, considering growth factors and market dynamics, including declines in New York and New Jersey. These developments indicate a positive outlook from analysts, with firms maintaining favorable ratings on Allstate’s stock.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.